314 results on '"Freimark D"'
Search Results
2. Production Process for Stem Cell Based Therapeutic Implants: Expansion of the Production Cell Line and Cultivation of Encapsulated Cells
3. Prevalence and clinical outcomes of dystrophin-associated dilated cardiomyopathy without severe skeletal myopathy
4. Online- and offline- monitoring of stem cell expansion on microcarrier
5. Bioenergetic and metabolic impairments in Duchenne Muscular Dystrophy (DMD) patients' iPSC-derived cardiomyocytes
6. Gender variability in the clinical phenotype of hypertrophic cardiomyopathy
7. Evidence for fractal correlation properties in variations of peripheral arterial tone during REM sleep
8. P988Echocardiographic characterization of heart failure in hypertrophic cardiomyopathy
9. Encapsulation of Human Mesenchymal Stem Cells Via Protein Cross Linking for Intervertebral Disc Regeneration: P227 (EI0203)
10. Measles Virus Production Process for the Use in Cancer Therapy: P201 (EI0201)
11. Regeneration of the Intervertebral Disc (IVD) Using in Vitro Differentiated Stem Cells: P170 (EI0097)
12. Analysis of Ceramic and Polymeric Membranes Using Fluorescent-Labeled Endotoxin: P123 (EI0199)
13. Short- and long-term treatment of dilutional hyponatraemia with satavaptan, a selective arginine vasopressin V2-receptor antagonist: the DILIPO study
14. CA125 Independently Predicts Right Atrial Pressure in Advanced Heart Failure Patients
15. Hepatitis B Seropositivity is Associated with Increased Cardiac Allograft Vasculopathy after Heart Transplantation
16. CERAMIC MEMBRANES FOR ENDOTOXIN REMOVAL: P23 (246)
17. REGENERATION OF INTERVERTEBRAL DISC (IVD) USINGIN VITRO DIFFERENTIATED STEM CELLS: O82 (245)
18. STEM BASED CELL THERAPEUTIC IMPLANTS: PRODUCTION AND STORAGE: O20 (248)
19. NEED OF IMAGING METHODS FOR BIOENGINEERING OF THREE DIMENSIONAL CELL CULTURE, INCLUDING MATRIX DEVELOPMENT INTRODUCTION: O9
20. Improved prognosis of patients presenting with clinical markers of spontaneous reperfusion during acute myocardial infarction
21. Does total orthotopic heart transplantation offer improved hemodynamics during cellular rejection events?
22. P380Early post-stress decrease in cardiac peformance by impedance cardiography and its relation to the severity and extent of ischemia by myocardial perfusion imaging
23. Does Donor-Recipient Age Difference Matter in the Outcome of Heart Transplantation?
24. Weight Gain Post Heart Transplantation is Associated with an Increased Risk for Allograft Vasculopathy and Rejection
25. Low Serum Magnesium is Associated with Increased Mortality and Cardiac Allograft Vasculopathy Following Heart Transplantation
26. Treatment with a Statin or Spironolactone is Associated with a Reduced Risk for Primary Graft Dysfunction and Mortality
27. Donor Hormonal Thyroid Therapy is Associated with Increased Risk of Primary Graft Dysfunction after Heart Transplantation
28. Metformin Therapy is Associated with Reduced Risk of Vasculopathy and Cardiovascular Mortality after Heart Transplantation
29. Hypomagnesemia is Associated with New-Onset Diabetes Mellitus Following Heart Transplantation
30. Rescue Coronary Angiography after Failed Thrombolysis: A Real-Life Experience
31. Immunosuppression induction with rabbit antithymocyte globulin in heart transplantation patients: 6-year experience at the Sheba Medical Center
32. P2814New-onset (De-Novo) acute heart failure versus acute decompensated chronic heart failure: differences in early intermediate and long-term mortality
33. Donor-recipient Ethnic Matching Impacts Short and Long-term Results of Heart Transplantation
34. Improved Long Term Outcomes after Heart Transplantation Utilizing Donors with Traumatic Mode of Brain Death
35. Recurrent Acute Cellular Rejection Graded ISHLT 1R Early After Heart Transplantation Negatively Affects Long-term Outcomes
36. Relation of Age to Risk of Major Rejections, Allograft Vasculopathy, and Long-term Mortality in a Contemporary Cohort of Patients Undergoing Heart Transplantation
37. High Variability in Tacrolimus Trough Levels is Associated With Rejections After Heart Transplantation
38. P3248Investigating dilated cardiomyopathy caused by dystrophin mutations using duchenne muscular dystrophy-patients induced pluripotent stem cell-derived cardiomyocytes
39. P1456Chemotherapy and biological therapy induced cardio-toxicity-data from a tertiary center
40. P3496Functional abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from titin-mutated dilated cardiomyopathy patients
41. Metformin Treatment After Heart Transplantation Is Associated with Reduced Malignancy Rate
42. Early Aspirin Initiation Following Heart Transplantation Decreases the Risk of Allograft Vasculopathy During Long-Term Follow-Up
43. Risk of Early, Intermediate, and Late Rejection Following Heart Transplantation (HT): Trends Over the Past 25 Years and Relation to Changes in Medical Management
44. Heart Transplantation in LVAD Patient Following Donor's Extracorporeal Membrane Oxygenation Support: Is It Safe?
45. P1088Match and mismatch between opening area and resistance in mild and moderate rheumatic mitral stenosisP1089When should cardiovascular magnetic resonance imaging be considered in patients with chronic aortic or mitral regurgitation?P1090Echocardiographic characteristics of aortic valve fenestration with aortic regurgitation for aortic valve repairP1091Aortic regurgitation assessment by 3D transesophageal echocardiography vena contracta area: usefulness and comparison with 2D methods.P1092Characterising cardiomyopathy in mitral regurgitation due to barlow disease: role of CMRP1093Compensatory peripheral increase in artero-venous o2 difference to severe functional mitral regurgitation in heart failureP1094Prognostic impact of concomitant atrioventricular valve regurgitation in patients undergoing transcatheter aortic valve implantationP1095Morphological characterization of vegetations by real-time three-dimensional transesophageal echocardiography in infective endocarditis: prognostic impactP1096Relation between causative pathogen and echocardiographic findings in patients with infective endocarditis: is there an association and is it clinically relevant?P1097Aortic and mitral valve infective endocarditis: different clinical and echocardiographic features and peculiar complication ratesP1098Vegetation size relevance and impact on prognosis in patients with infective endocarditisP1099Causes of death on the valvular heart disease surveillance list- a 5 year auditP1100Left ventricular non-compaction and idiopathic dilated cardiomyopathy: the significant diagnostic value of longitudinal strainP1101The role of echocardiography in the management of diuretics withdrawal in patients with chronic heart failure and severely reduced ejection fraction: a prospective cohort studyP1102Outcomes in paediatric new onset left ventricle dysfunction and dilatation: differences between post-myocarditis and DCMP1103De novo mitral regurgitation as a cause of heart failure exacerbation in hypertrophic cardiomyopathyP1104Correlation of conventional and new echocardiograhic parameters with sudden cardiac death risk score in patients with hypertrophic cardiomyopathyP1105Inverse correlation between myocardial fibrosis and left ventricular function in rheumatic mitral stenosis: a preliminary study with cardiac magnetic resonanceP1106Left ventricular diastolic dysfunction and cardiac sympathetic derangement in patients with Anderson-Fabry disease: a 2D speckle tracking echocardiography and cardiac 123I-MIBG studyP1107Left ventricular hypertrophy and mild cognitive impairment as markers for target organ damage in hypertensive patients with multiple risk factorsP1108Subclinical left ventricular dysfunction in asymptomatic type 1 diabetic childrenP1109Minimal differences shown by echocardiography and NT-proBNP level distinguishing cardiotoxic effect related to breast cancer therapy in patients with or without HER2 expression.P1110Speed of recovery of left ventricular function is not related to the prognosis of takotsubo cardiomyopathy - a portuguese multicenter studyP1111Myocardial dysfunction in Takotsubo cardiomyopathy - more than meets the eye?P1112Obstructive sleep apnea and echocardiographic parameters
46. The Impact of Gender Mismatching on Early and Late Outcomes Following Heart Transplantation
47. Trends of Early and Late Rejection Rates Following Heart Transplantation Over the Past Two Decades: Real World Data from a National Tertiary Center Registry
48. (1106) - Relation of Age to Risk of Major Rejections, Allograft Vasculopathy, and Long-term Mortality in a Contemporary Cohort of Patients Undergoing Heart Transplantation
49. (1082) - High Variability in Tacrolimus Trough Levels is Associated With Rejections After Heart Transplantation
50. (824) - Improved Long Term Outcomes after Heart Transplantation Utilizing Donors with Traumatic Mode of Brain Death
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.